The Central Drugs Standard Control Organisation (CDSCO), India’s national drug regulatory authority, has issued a sweeping public notice clarifying that cosmetic products are strictly legally barred from being administered in injectable form.

The directive, enacted via a formal advisory, directly targets the massive surge in unregulated aesthetic treatments—such as glutathione “skin-whitening” drips, unauthorized vitamin cocktails, and unapproved hair-growth injections—frequently marketed by local wellness centers, salons, and social media influencers.

1. The Legal Rationale: Defining a “Cosmetic”

The regulatory action rests on the foundational definitions established under the Drugs and Cosmetics Act, 1940, and the Cosmetics Rules, 2020:

• The External-Only Mandate: Under Indian law, cosmetics are legally defined only as articles intended to be rubbed, poured, sprinkled, or sprayed on, or introduced into, or otherwise applied to, the human body for cleansing, beautifying, promoting attractiveness, or altering appearance.
• The Injectable Disqualification: The CDSCO explicitly declared: “Products supplied in the form of injectable preparations do not fall under the definition of cosmetics. No cosmetic is permitted to be used as an injection by consumers, professionals, or aesthetic clinics.”
• No Therapeutic Claims: A product registered under a cosmetic license cannot legally claim to cure, mitigate, or treat an underlying medical or dermatological condition. Doing so immediately reclassifies it as a drug, exposing the manufacturer or clinic to criminal penalties for distributing unapproved medications.

2. Why the Regulator Intervened Now

The CDSCO’s intervention comes at a critical juncture for India’s rapidly growing, multi-billion-dollar aesthetic medicine ecosystem:

• The Legal Grey Zone: Many commercial clinics have been exploiting a regulatory loophole—importing high-strength chemicals under loose cosmetic licenses, and then injecting them directly into the tissue or bloodstream of consumers.
• The Health Risks: Medical associations have repeatedly flagged a rising wave of adverse events stemming from these unauthorized procedures, ranging from localized infections and severe skin necrosis to systemic complications like liver toxicity and kidney failure, often because the products are administered by inadequately trained salon staff rather than board-certified specialists.
• The Influencer Boom: Aggressive digital marketing campaigns promoting “instant glow treatments” or “permanent skin-lightening transformations” have led to widespread consumer confusion regarding the clinical difference between a safe topical cosmetic and an invasive medical procedure.

3. What Does This Mean for Botox, Fillers, and Weight-Loss Jabs?

The notice does not mean that medical aesthetic procedures are completely banned in India. Instead, it sharply separates consumer cosmetics from regulated drugs:

4. Enforcement and Public Reporting

The government has urged the public to act as active eyes on the ground. Consumers and professionals can report any instances of salons or clinics offering injectable cosmetic treatments, using unauthorized ingredients (such as restricted melanin blockers like hydroquinone), or utilizing defaced or misleading labels directly to the apex regulator at [email protected] or to their respective State Licensing Authorities.